Biotech

All Articles

Novo inks $600M NanoVation bargain to analyze hereditary medicines ex-liver

.Novo Nordisk is continuing its own press in to genetic medicines, agreeing to pay NanoVation Therap...

Innovent links cytokine to intestines cancer cells actions

.Innovent Biologics has actually made the instance that its checkpoint inhibitor-cytokine combinatio...

Merck, Daiichi ADC hits objective in phase 3 lung cancer study

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens artificial intelligence concentrate along with collab to decide on cancer targets

.5 months after Rakovina Rehabs pivoted toward expert system, the cancer-focused biotech has actuall...

Ascendis' dwarfism drug smash hits in stage 3, threatens BioMarin

.Ascendis Pharma has become a prospective threat to BioMarin's Voxzogo, mentioning stage 3 growth di...

Despite ph. 3 miss, Alkeus observes path in advance for eye condition asset

.Though Alkeus Pharmaceuticals' oral eye ailment possession neglected to significantly minimize geog...

Kairos goes public with $6M IPO to money trials of cancer medication

.Along with a triad of biotechs hitting the Nasdaq on Friday, it was effortless to miss out on a sma...

Vaccine as well as Keytruda combo successful in squamous cell carcinoma

.Immune system gate inhibitors are the superheroes of cancer therapy. Medications like Bristol Myers...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of significant leadership hirings, shootings ...

Regeneron's Opdualag competitor shows 57% reaction rate

.Regeneron is back along with long-lasting consequence for its own LAG-3 prevention and PD-1 prevent...